Evaluation of soluble junctional adhesion molecule-A as a biomarker of human brain endothelial barrier breakdown

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  Haarmann, Axel ^a   Deiß, Annika ^a   Prochaska, Jürgen ^a   Foerch, Christian ^b   Weksler, Babette ^c   Romero, Ignacio ^d   Couraud, Pierre Olivier ^e   Stoll, Guido ^a   Rieckmann, Peter ^a,f   Buttmann, Mathias ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d OPEN UNIVERSITY   (United Kingdom)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DEXTRAN; JUNCTIONAL ADHESION MOLECULE A; OCCLUDIN; PROTEIN ZO1; CELL ADHESION MOLECULE; JUNCTIONAL ADHESION MOLECULE;

ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; BRAIN ISCHEMIA; CELL CULTURE; CELL IMMORTALIZATION; CELL MEMBRANE PERMEABILITY; CELL SURFACE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOSKELETON; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IMMUNOCYTOCHEMISTRY; INFLAMMATION; MULTIPLE SCLEROSIS; NEUROPROTECTION; PROTEIN SECRETION; REOXYGENATION; SUPERNATANT; TIGHT JUNCTION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING; BRAIN; BRAIN CIRCULATION; FLOW CYTOMETRY; GLYCOSYLATION; IMMUNOHISTOCHEMISTRY; METABOLISM; VASCULARIZATION;

BIOLOGICAL MARKERS; BLOOD-BRAIN BARRIER; BLOTTING, WESTERN; BRAIN; CELL ADHESION MOLECULES; CEREBROVASCULAR CIRCULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GLYCOSYLATION; HUMANS; IMMUNOHISTOCHEMISTRY;

EID: 78149451606     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013568     Document Type: Article

References (43)

1. Kornecki E, Walkowiak B, Naik UP, Ehrlich YH (1990) Activation of human platelets by a stimulatory monoclonal antibody. J Biol Chem 265: 10042-10048.
2. Martin-Padura I, Lostaglio S, Schneemann M, Williams L, Romano M, et al. (1998) Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J Cell Biol 142: 117-127.
3. Williams LA, Martin-Padura I, Dejana E, Hogg N, Simmons DL (1999) Identification and characterisation of human Junctional Adhesion Molecule (JAM). Mol Immunol 36: 1175-1188.
4. Steed E, Balda MS, Matter K. Dynamics and functions of tight junctions. Trends Cell Biol 20: 142-149.
5. Mandell KJ, Holley GP, Parkos CA, Edelhauser HF (2006) Antibody blockade of junctional adhesion molecule-A in rabbit corneal endothelial tight junctions produces corneal swelling. Invest Ophthalmol Vis Sci 47: 2408-2416.
6. Liang TW, DeMarco RA, Mrsny RJ, Gurney A, Gray A, et al. (2000) Characterization of huJAM: evidence for involvement in cell-cell contact and tight junction regulation. Am J Physiol Cell Physiol 279: C1733-1743.
7. Liu Y, Nusrat A, Schnell FJ, Reaves TA, Walsh S, et al. (2000) Human junction adhesion molecule regulates tight junction resealing in epithelia. J Cell Sci 113 (Pt 13): 2363-2374.
8. Mandell KJ, McCall IC, Parkos CA (2004) Involvement of the junctional adhesion molecule-1 (JAM1) homodimer interface in regulation of epithelial barrier function. J Biol Chem 279: 16254-16262.
9. Vestweber D, Broermann A, Schulte D. Control of endothelial barrier function by regulating vascular endothelial-cadherin. Curr Opin Hematol 17: 230-236.
10. Martinez-Estrada OM, Manzi L, Tonetti P, Dejana E, Bazzoni G (2005) Opposite effects of tumor necrosis factor and soluble fibronectin on junctional adhesion molecule-A in endothelial cells. Am J Physiol Lung Cell Mol Physiol 288: L1081-1088.
11. Ostermann G, Weber KS, Zernecke A, Schroder A, Weber C (2002) JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in transendothelial migration of leukocytes. Nat Immunol 3: 151-158.
12. Ozaki H, Ishii K, Horiuchi H, Arai H, Kawamoto T, et al. (1999) Cutting edge: combined treatment of TNF-alpha and IFN-gamma causes redistribution of junctional adhesion molecule in human endothelial cells. J Immunol 163: 553-557.
13. Weber C, Fraemohs L, Dejana E (2007) The role of junctional adhesion molecules in vascular inflammation. Nat Rev Immunol 7: 467-477.
14. Severson EA, Parkos CA (2009) echanisms of outside-in signaling at the tight junction by junctional adhesion molecule A. Ann N Y Acad Sci 1165: 10-18.
15. Shaw SK, Ma S, Kim B, Rao RM, Hartman CU, et al. (2004) Coordinated redistribution of leukocyte LFA-1 and endothelial cell ICAM-1 accompany neutrophil transmigration. J Exp Med 200: 1571-1580.
16. Zernecke A, Liehn EA, Fraemohs L, von Hundelshausen P, Koenen RR, et al. (2006) Importance of junctional adhesion molecule-A for neointimal lesion formation and infiltration in atherosclerosis-prone mice. Arterioscler Thromb Vasc Biol 26: e10-13.
17. Khandoga A, Kessler JS, Meissner H, Hanschen M, Corada M, et al. (2005) Junctional adhesion molecule-A deficiency increases hepatic ischemia-reperfusion injury despite reduction of neutrophil transendothelial migration. Blood 106: 725-733.
18. Corada M, Chimenti S, Cera MR, Vinci M, Salio M, et al. (2005) Junctional adhesion molecule-A-deficient polymorphonuclear cells show reduced diapedesis in peritonitis and heart ischemia-reperfusion injury. Proc Natl Acad Sci U S A 102: 10634-10639.
19. Salifu MO, Kolff Q, Murty P, Haria DM, Zimpa M, et al. (2007) Relationship between the soluble F11 receptor and markers of inflammation in hemodialysis patients. J Investig Med 55: 115-119.
20. Ong KL, Leung RY, Babinska A, Salifu MO, Ehrlich YH, et al. (2009) Elevated plasma level of soluble F11 receptor/junctional adhesion molecule-A (F11R/JAM-A) in hypertension. Am J Hypertens 22: 500-505.
21. Cavusoglu E, Kornecki E, Sobocka MB, Babinska A, Ehrlich YH, et al. (2007) Association of plasma levels of F11 receptor/junctional adhesion molecule-A (F11R/JAM-A) with human atherosclerosis. J Am Coll Cardiol 50: 1768-1776.
22. Hou Y, Rabquer BJ, Gerber ML, Del Galdo F, Jimenez SA, et al. (2009) Junctional adhesion molecule-A is abnormally expressed in diffuse cutaneous systemic sclerosis skin and mediates myeloid cell adhesion. Ann Rheum Dis.
23. Koenen RR, Pruessmeyer J, Soehnlein O, Fraemohs L, Zernecke A, et al. (2009) Regulated release and functional modulation of junctional adhesion molecule A by disintegrin metalloproteinases. Blood 113: 4799-4809.
24. Ostermann G, Fraemohs L, Baltus T, Schober A, Lietz M, et al. (2005) Involvement of JAM-A in mononuclear cell recruitment on inflamed or atherosclerotic endothelium: inhibition by soluble JAM-A. Arterioscler Thromb Vasc Biol 25: 729-735.
25. Kallmann BA, Wagner S, Hummel V, Buttmann M, Bayas A, et al. (2002) Characteristic gene expression profile of primary human cerebral endothelial cells. Faseb J 16: 589-591.
26. Banks WA. Mouse models of neurological disorders: A view from the blood-brain barrier. Biochim Biophys Acta 1802: 881-888.
27. Yeung D, Manias JL, Stewart DJ, Nag S (2008) Decreased junctional adhesion molecule-A expression during blood-brain barrier breakdown. Acta Neuropathol 115: 635-642.
28. Alvarez JI, Cayrol R, Prat A. Disruption of central nervous system barriers in multiple sclerosis. Biochim Biophys Acta.
29. Padden M, Leech S, Craig B, Kirk J, Brankin B, et al. (2007) Differences in expression of junctional adhesion molecule-A and beta-catenin in multiple sclerosis brain tissue: increasing evidence for the role of tight junction pathology. Acta Neuropathol 113: 177-186.
30. Del Maschio A, De Luigi A, Martin-Padura I, Brockhaus M, Bartfai T, et al. (1999) Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis is inhibited by an antibody to junctional adhesion molecule (JAM). J Exp Med 190: 1351-1356.
31. Buttmann M, Lorenz A, Weishaupt A, Rieckmann P (2007) Atorvastatin partially prevents an inflammatory barrier breakdown of cultured human brain endothelial cells at a pharmacologically relevant concentration. J Neurochem 102: 1001-1008.
32. Weksler BB, Subileau EA, Perriere N, Charneau P, Holloway K, et al. (2005) Blood-brain barrier-specific properties of a human adult brain endothelial cell line. Faseb J 19: 1872-1874.
33. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, et al. (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50: 121-127.
34. Dvorak F, Haberer I, Sitzer M, Foerch C (2009) Characterisation of the diagnostic window of serum glial fibrillary acidic protein for the differentiation of intracerebral haemorrhage and ischaemic stroke. Cerebrovasc Dis 27: 37-41.
35. Huang W, Eum SY, Andras IE, Hennig B, Toborek M (2009) PPARalpha and PPARgamma attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities. Faseb J 23: 1596-1606.
36. Betz AL (1996) Alterations in cerebral endothelial cell function in ischemia. Adv Neurol 71: 301-311; discussion 311-303.
37. Sandoval KE, Witt KA (2008) Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiol Dis 32: 200-219.
38. Dore-Duffy P, Newman W, Balabanov R, Lisak RP, Mainolfi E, et al. (1995) Circulating, soluble adhesion proteins in cerebrospinal fluid and serum of patients with multiple sclerosis: correlation with clinical activity. Ann Neurol 37: 55-62.
39. Hartung HP, Reiners K, Archelos JJ, Michels M, Seeldrayers P, et al. (1995) Circulating adhesion molecules and tumor necrosis factor receptor in multiple sclerosis: correlation with magnetic resonance imaging. Ann Neurol 38: 186-193.
40. Bitsch A, Klene W, Murtada L, Prange H, Rieckmann P (1998) A longitudinal prospective study of soluble adhesion molecules in acute stroke. Stroke 29: 2129-2135.
41. Blann A, Kumar P, Krupinski J, McCollum C, Beevers DG, et al. (1999) Soluble intercelluar adhesion molecule-1, E-selectin, vascular cell adhesion molecule-1 and von Willebrand factor in stroke. Blood Coagul Fibrinolysis 10: 277-284.
42. Hummel V, Kallmann BA, Wagner S, Fuller T, Bayas A, et al. (2001) Production of MMPs in human cerebral endothelial cells and their role in shedding adhesion molecules. J Neuropathol Exp Neurol 60: 320-327.
43. Singh RJ, Mason JC, Lidington EA, Edwards DR, Nuttall RK, et al. (2005) Cytokine stimulated vascular cell adhesion molecule-1 (VCAM-1) ectodomain release is regulated by TIMP-3. Cardiovasc Res 67: 39-49.